ArticleFolia microbiologica2025
Probiotic characteristics and safety evaluation of acid-tolerant lactic acid bacteria isolated from Suancai, a popular fermented vegetable in Northeast China.
Article in Folia microbiologica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This study aimed to isolate acid-tolerant lactic acid bacteria from Suancai, a traditional Chinese fermented vegetable, and evaluate their potential and safety as candidate probiotics. Fifteen dominant lactic acid bacteria strains were isolated from spontaneously fermented Suancai, and four isolates were selected based on their tolerance to acid and bile, as well as their autoaggregation, coaggregation, cell surface hydrophobicity, and adhesion capabilities. Based on 16S rRNA and pheS gene sequence analyses, the four strains were identified as Lactiplantibacillus plantarum (strain S5) and Levilactobacillus brevis (strains S1, H1, and H2). These strains were further evaluated for multiple in vitro probiotic properties. All four exhibited cholesterol removal capacity, DPPH and hydroxyl radical scavenging activity, gamma-aminobutyric acid production, and nitrite degradation ability. α-Glucosidase inhibitory activity was observed in three strains, with the exception of Levilactobacillus brevis S1. Additionally, all strains displayed antimicrobial activity against Escherichia coli, Staphylococcus aureus, and Salmonella paratyphi B. Safety assessment revealed that the strains were sensitive to ampicillin, erythromycin, and penicillin, resistant to gentamycin, and negative for indole production and hemolytic activity. In conclusion, the four selected strains demonstrated favorable probiotic characteristics and safety profile, supporting their potential as candidate probiotics for functional food application.
Indexed as
Identifiers
41348297What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.